GlobalData on MSN3d
GSK and UK researchers plan to study Shingrix and dementia risk reduction link
The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
BioSpace3d
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...
PMLive4d
GSK to explore link between Shingrix and dementia risk in new UK research collaboration
GSK has announced a partnership with the UK Dementia Research Institute and Health Data Research UK to explore a potential ...
pharmaphorum4d
GSK taps into UK health data for dementia study
To test it prospectively, GSK will work with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) ...
Fierce Biotech4d
GSK takes advantage of natural experiment to study whether shingles vaccine can reduce dementia risk
After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...
GSK studying if best-selling shingles vaccine lowers dementia risk
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
Money Talks News on MSN5d
This Vaccine Is Now Tied to a 17% Lower Dementia Risk
Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...